NDC-1308 by Endece Neural

[durgastiger]

Potential Remyelination Therapy for MS
NDC-1308, Advancing in Preclinical Studies
JULY 2, 2016

Endece Neural was issued an additional U.S. patent for its lead investigational product, NDC-1308. The drug is under development to repair the myelin sheath damaged in multiple sclerosis (MS), a major causing disease progression and increasing disability.

Full article HERE

[ru4cats]

Maybe in my lifetime but probably not in time for me. However, I still say MS will be controlled within the decade and become like HIV.

[durgastiger]

Maybe in my lifetime but probably not in time for me. However, I still say MS will be controlled within the decade and become like HIV.

The MSAA had also awarded them with a grant. I truly feel that a cure or close to a cure[remyelination] will be from the MSAA or NMSS awarding a grant then the federal [democratic]government will step in and nationalize the distribution.